• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Nimbus Therapeutics - Articles and news items

NDI-010976

Nimbus initiates Phase I clinical programme for NDI-010976 for the treatment of NASH

Industry news / 22 April 2015 / Victoria White

Nimbus Therapeutics has initiated a Phase I clinical programme for NDI-010976 for the treatment of NASH and related fatty liver disease-spectrum disorders…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +